Effect of VDRA on survival in incident hemodialysis patients: Results of the FARO-2 observational study

VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey.

Cozzolino M
Brancaccio D
Cannella G
Messa P
Gesualdo L
Marangella M
LoDeserto C
Pozzato M
Rombolà G
Costanzo AM
di Luzio Paparatti U
Mazzaferro S
Andreucci VE
Bellinghieri G
Bigazzi R
Bolasco P
Bonomini M
Cancarini G
Caruso MR
Cascone C
Di Luca M
Emiliani G
Lombardi L
Malberti F
Morosetti M
Panzetta G
Procaccini DA
Procida M
Quarello F
Salvadori M
Schena FP
STEFONI, SERGIO

January 2012

BACKGROUND: Chronic kidney disease (CKD) patients affected by mineral bone disorders (MBD) have high...

VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey.

Cozzolino M1, Brancaccio D, Cannella G, Messa P, Gesualdo L, Marangella M, LoDeserto C, Pozzato M, Rombolà G, Costanzo AM, di Luzio Paparatti U, Mazzaferro S
FARO Study Group. Andreucci VE, Bellinghieri G, Bigazzi R, Bolasco P, Bonomini M, Cancarini G, Caruso MR, Cascone C, Di Luca M, Emiliani G, Lombardi L, Malberti F, Morosetti M, Panzetta G, Procaccini DA, Procida M, Quarello F, Salvadori M, Schena FP, Stefoni S.

January 2012

BACKGROUND: Chronic kidney disease (CKD) patients affected by mineral bone disorders (MBD) have ...

Vitamin d receptor activators and clinical outcomes in chronic kidney disease

L. Gravellone
M.A. Rizzo
V. Martina
N. Mezzina
A. Regalia
M. Gallieni

January 2011

Vitamin D deficiency appears to be an underestimated risk factor for cardiovascular disease in patie...

Effect of VDRA on survival in incident hemodialysis patients: Results of the FARO-2 observational study

Messa, P
Cozzolino, M
Brancaccio, D
Cannella, G
Malberti, F
Costanzo, Am
Paparatti, Udl
Festa, V
Gualberti, G
Mazzaferro, S
FARO Study Group
Morosetti, M

January 2015

Mortality rate among patients with stage five chronic kidney disease (CKD) maintained on hemodialysi...

Effect of VDRA on survival in incident hemodialysis patients: results of the FARO-2 observational study

P. Messa
M. Cozzolino
D. Brancaccio
G. Cannella
F. Malberti
A.M. Costanzo
U. di Luzio Paparatti
V. Festa
G. Gualberti
S. Mazzaferro

February 2015

Background Mortality rate among patients with stage five chronic kidney disease (CKD) maintained on ...

Effect of VDRA on survival in incident hemodialysis patients. results of the FARO-2 observational study

Messa, Piergiorgio
Cozzolino, Mario
Brancaccio, Diego
Cannella, Giuseppe
Malberti, Fabio
Costanzo, Anna Maria
Paparatti, Umberto Di Luzio
Festa, Vincenzo
Gualberti, Giuliana
Mazzaferro, Sandro

January 2015

Background: Mortality rate among patients with stage five chronic kidney disease (CKD) maintained on...

Mortality reduction by vitamin D receptor activation in end-stage renal disease: a commentary on the robustness of current data

Vervloet, M.G.
Twisk, J.W.R.

January 2009

Background. Debate exists about assumed mortality effects of the use of vitamin D receptor activator...

Survival Benefits with Vitamin D Receptor Activation: New Insights Since 2003

Csaba P. Kovesdy

September 2016

The introduction of calcitriol followed by several of its analogs in the 1990s made vitamin D recept...

Secondary hyperparathyroidism in chronic dialysis patients : results of the Italian FARO survey on treatment and mortality

D. Brancaccio
M.G. Cozzolino
G. Cannella
P. Messa
M. Bonomini
G. Cancarini
M.R. Caruso
C. Cascone
A.M. Costanzo
U. Di Luzio Paparatti
S. Mazzaferro

August 2011

Introduction: Vitamin D receptor activator (VDRA) therapy has been shown to be associated with reduc...

Secondary hyperparathyroidism in chronic dialysis patients: Results of the Italian FARO survey on treatment and mortality

Diego Brancaccio
Mario Cozzolino
Giuseppe Cannella
Piergiorgio Messa
Mario Bonomini
Giovanni Cancarini
Maria Rosa Caruso
Carmelo Cascone
Anna Maria Costanzo
Umberto Di Luzio Paparatti
Sandro Mazzaferro

January 2011

Introduction: Vitamin D receptor activator (VDRA) therapy has been shown to be associated with reduc...

Cardiovascular effects of VDR and CaSR activation

D. Brancaccio
M.G. Cozzolino

January 2009

Cardiovascular complications are the most common cause of death in uremic patients, especially those...

The role of vitamin D receptor activation in chronic kidney disease

M. Cozzolino
P. Malindretos

January 2010

The death rate from cardiovascular disease for dialysis patients is much higher than the general pop...

Vitamin D receptor activation and prevention of arterial ageing [Reprint of]

M. Cozzolino
A. Stucchi
M.A. Rizzo
L. Soldati
D. Cusi
P. Ciceri
I. Brenna
F. Elli
M. Gallieni

January 2013

In chronic kidney disease (CKD) patients, cardiovascular (CV) morbidity and mortality rate is higher...

Importance of vitamin D receptor activation in clinical practise

M.G. Cozzolino
G. Fallabrino
S. Pasho
L. Olivi
P. Ciceri
E.M. Volpi
M.A. Gallieni
D. Brancaccio

January 2009

Continuously emerging evidence indicates that defi ciencies in 25-hydroxyvitamin D and consequently ...

Association of activated vitamin D treatment and mortality in chronic kidney disease.

Kovesdy, Csaba P
Ahmadzadeh, Shahram
Anderson, John E
Kalantar-Zadeh, Kamyar

February 2008

BackgroundTreatment of secondary hyperparathyroidism (SHPT) with activated vitamin D analogues is as...

VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey.

Cozzolino M
Brancaccio D
Cannella G
Messa P
Gesualdo L
Marangella M
LoDeserto C
Pozzato M
Rombolà G
Costanzo AM
di Luzio Paparatti U
Mazzaferro S
Andreucci VE
Bellinghieri G
Bigazzi R
Bolasco P
Bonomini M
Cancarini G
Caruso MR
Cascone C
Di Luca M
Emiliani G
Lombardi L
Malberti F
Morosetti M
Panzetta G
Procaccini DA
Procida M
Quarello F
Salvadori M
Schena FP
STEFONI, SERGIO

January 2012

BACKGROUND: Chronic kidney disease (CKD) patients affected by mineral bone disorders (MBD) have high...

VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey.

Cozzolino M1, Brancaccio D, Cannella G, Messa P, Gesualdo L, Marangella M, LoDeserto C, Pozzato M, Rombolà G, Costanzo AM, di Luzio Paparatti U, Mazzaferro S
FARO Study Group. Andreucci VE, Bellinghieri G, Bigazzi R, Bolasco P, Bonomini M, Cancarini G, Caruso MR, Cascone C, Di Luca M, Emiliani G, Lombardi L, Malberti F, Morosetti M, Panzetta G, Procaccini DA, Procida M, Quarello F, Salvadori M, Schena FP, Stefoni S.

January 2012

BACKGROUND: Chronic kidney disease (CKD) patients affected by mineral bone disorders (MBD) have ...

Vitamin d receptor activators and clinical outcomes in chronic kidney disease

L. Gravellone
M.A. Rizzo
V. Martina
N. Mezzina
A. Regalia
M. Gallieni

January 2011

Vitamin D deficiency appears to be an underestimated risk factor for cardiovascular disease in patie...

Effect of VDRA on survival in incident hemodialysis patients: Results of the FARO-2 observational study

Messa, P
Cozzolino, M
Brancaccio, D
Cannella, G
Malberti, F
Costanzo, Am
Paparatti, Udl
Festa, V
Gualberti, G
Mazzaferro, S
FARO Study Group
Morosetti, M

January 2015

Mortality rate among patients with stage five chronic kidney disease (CKD) maintained on hemodialysi...

Effect of VDRA on survival in incident hemodialysis patients: results of the FARO-2 observational study

P. Messa
M. Cozzolino
D. Brancaccio
G. Cannella
F. Malberti
A.M. Costanzo
U. di Luzio Paparatti
V. Festa
G. Gualberti
S. Mazzaferro

February 2015

Background Mortality rate among patients with stage five chronic kidney disease (CKD) maintained on ...

Effect of VDRA on survival in incident hemodialysis patients. results of the FARO-2 observational study

Messa, Piergiorgio
Cozzolino, Mario
Brancaccio, Diego
Cannella, Giuseppe
Malberti, Fabio
Costanzo, Anna Maria
Paparatti, Umberto Di Luzio
Festa, Vincenzo
Gualberti, Giuliana
Mazzaferro, Sandro

January 2015

Background: Mortality rate among patients with stage five chronic kidney disease (CKD) maintained on...

Mortality reduction by vitamin D receptor activation in end-stage renal disease: a commentary on the robustness of current data

Vervloet, M.G.
Twisk, J.W.R.

January 2009

Background. Debate exists about assumed mortality effects of the use of vitamin D receptor activator...

Survival Benefits with Vitamin D Receptor Activation: New Insights Since 2003

Csaba P. Kovesdy

September 2016

The introduction of calcitriol followed by several of its analogs in the 1990s made vitamin D recept...

Secondary hyperparathyroidism in chronic dialysis patients : results of the Italian FARO survey on treatment and mortality

D. Brancaccio
M.G. Cozzolino
G. Cannella
P. Messa
M. Bonomini
G. Cancarini
M.R. Caruso
C. Cascone
A.M. Costanzo
U. Di Luzio Paparatti
S. Mazzaferro

August 2011

Introduction: Vitamin D receptor activator (VDRA) therapy has been shown to be associated with reduc...

Secondary hyperparathyroidism in chronic dialysis patients: Results of the Italian FARO survey on treatment and mortality

Diego Brancaccio
Mario Cozzolino
Giuseppe Cannella
Piergiorgio Messa
Mario Bonomini
Giovanni Cancarini
Maria Rosa Caruso
Carmelo Cascone
Anna Maria Costanzo
Umberto Di Luzio Paparatti
Sandro Mazzaferro

January 2011

Introduction: Vitamin D receptor activator (VDRA) therapy has been shown to be associated with reduc...

Cardiovascular effects of VDR and CaSR activation

D. Brancaccio
M.G. Cozzolino

January 2009

Cardiovascular complications are the most common cause of death in uremic patients, especially those...

The role of vitamin D receptor activation in chronic kidney disease

M. Cozzolino
P. Malindretos

January 2010

The death rate from cardiovascular disease for dialysis patients is much higher than the general pop...

Vitamin D receptor activation and prevention of arterial ageing [Reprint of]

M. Cozzolino
A. Stucchi
M.A. Rizzo
L. Soldati
D. Cusi
P. Ciceri
I. Brenna
F. Elli
M. Gallieni

January 2013

In chronic kidney disease (CKD) patients, cardiovascular (CV) morbidity and mortality rate is higher...

Importance of vitamin D receptor activation in clinical practise

M.G. Cozzolino
G. Fallabrino
S. Pasho
L. Olivi
P. Ciceri
E.M. Volpi
M.A. Gallieni
D. Brancaccio

January 2009

Continuously emerging evidence indicates that defi ciencies in 25-hydroxyvitamin D and consequently ...

Association of activated vitamin D treatment and mortality in chronic kidney disease.

Kovesdy, Csaba P
Ahmadzadeh, Shahram
Anderson, John E
Kalantar-Zadeh, Kamyar

February 2008

BackgroundTreatment of secondary hyperparathyroidism (SHPT) with activated vitamin D analogues is as...

VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey.

Cozzolino M
Brancaccio D
Cannella G
Messa P
Gesualdo L
Marangella M
LoDeserto C
Pozzato M
Rombolà G
Costanzo AM
di Luzio Paparatti U
Mazzaferro S
Andreucci VE
Bellinghieri G
Bigazzi R
Bolasco P
Bonomini M
Cancarini G
Caruso MR
Cascone C
Di Luca M
Emiliani G
Lombardi L
Malberti F
Morosetti M
Panzetta G
Procaccini DA
Procida M
Quarello F
Salvadori M
Schena FP
STEFONI, SERGIO

January 2012

BACKGROUND: Chronic kidney disease (CKD) patients affected by mineral bone disorders (MBD) have high...

VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey.

Cozzolino M1, Brancaccio D, Cannella G, Messa P, Gesualdo L, Marangella M, LoDeserto C, Pozzato M, Rombolà G, Costanzo AM, di Luzio Paparatti U, Mazzaferro S
FARO Study Group. Andreucci VE, Bellinghieri G, Bigazzi R, Bolasco P, Bonomini M, Cancarini G, Caruso MR, Cascone C, Di Luca M, Emiliani G, Lombardi L, Malberti F, Morosetti M, Panzetta G, Procaccini DA, Procida M, Quarello F, Salvadori M, Schena FP, Stefoni S.

January 2012

BACKGROUND: Chronic kidney disease (CKD) patients affected by mineral bone disorders (MBD) have ...

Vitamin d receptor activators and clinical outcomes in chronic kidney disease

L. Gravellone
M.A. Rizzo
V. Martina
N. Mezzina
A. Regalia
M. Gallieni

January 2011

Vitamin D deficiency appears to be an underestimated risk factor for cardiovascular disease in patie...

Effect of VDRA on survival in incident hemodialysis patients: Results of the FARO-2 observational study

Abstract

Extracted data

Effect of VDRA on survival in incident hemodialysis patients: Results of the FARO-2 observational study

Abstract

Extracted data

Related items

Related items